IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study

Hepato-Gastroenterology

Volumn 50, Issue 49, 2003, Pages 297-300

  Franciosi, Claudio M ^a   Piacentini, Maria G ^a   Conti, Matteo ^a   Romano, Fabrizio ^a   Musco, Flavia ^a   Caprotti, Roberto ^a   Rovelli, Franco ^a   Uggeri, Franco ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Gastric cancer; Insulin like growth factor 1 (IGF 1); Insulin like growth factor binding proteins (IGF 1BP)

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; METASTASIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTRECTOMY; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS;

EID: 0037263364     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Aaronson S: Growth factors and cancer. Science 1991; 254:1146-1153.
2. Leroith D, Werner H, Beitner-Johnson D, Roberts CT: Molecular and cellular aspects of the insulin like growth factor 1 receptor. Endocr Rev 1995; 16:143-163.
3. Jones JI, Clemmons DR: Insulin like growth factors and their binding proteins: biological actions Endocr Rev 1995; 16:3-34.
4. Cohick WS, Clemmons DR: The insulin like growth factor. Ann Rev Physiol 1993; 55:131-153.
5. Leroith D, Clemmons DR, Nissley P, Richler M: Insulin like growth factor in health and disease. Ann Intern Med 1991; 116:854-862.
6. Harduin S, Gourmelen M, Noguiea P, Suren D, Roghan M, De Bouc Y, Povaoa G, Merimee TJ, Horsenlopp P, Binoux M: Molecular forms of serum insulin like growth factor- binding proteins in man: relationships with growth hormone and IGF-1 and physiological significance. J Clin Endocrinol Metab 1989; 69:1291-1301.
7. Conver CA: Regulation and physiological role of insulin like growth factor binding protein. Endocr J 1996; 43:543-548.
8. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JMG, Koenig KL, Lukanova A, Shore RE, Zeleniuch-Jacquotte A: Serum insulin like growth factor 1 and breast cancer. Int J Cancer 2000; 88:828-832.
9. Hankinson SE, Willet WC, Coldits GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer F, Pollak M: Circulating concentrations of insulin like growth factor 1 and risk of breast cancer. Lancet 1998; 351:1393-1396.
10. Chan JM, Stampfer MJ, Giovannucci E: Plasma IGF-1 and prostate cancer risk: a prospective study. Science 1998; 279:563-566.
11. Ma J, Pollak M, Giovannucci E, Chan JM, Tao T, Hennekens CH, Stampfer MJ: Prospective study of colorectal cancer risk in men and plasma levels of IGF-1 IGFBP-3 J Nat Cancer Inst 1999; 91:620-625.
12. Daughaday WH: Editorial: the possible autocrine/paracrine and endocrine roles of IGF-1 on human tumours. Endocrinol 1990; 127:1.
13. Macauley VM, Everard MJ, Teale JD, Trott PA, Vam Wyk JJ, Smith IE, Millar JL: Autocrine function for IGF 1 in human small cell lung cancer cell lines and fresh tumour cells. Cancer Research 1990; 50:2511 2517.
14. Thompson MA, Cox AJ, Whitehead RM, Jones HA: Autocrine regulation of human tumour cell proliferation by IGF-2: an in vitro model. Endocrinology 1990; 126:3033-3042.
15. Macauley VM: Insulin like growth factors and cancer. Eur J Cancer 1992; 65:311-320.
16. Guo YS, Beauchamp RD, Jin GF, Townsend CM, Thompson JC: Insulin growth factor binding protein modulates the growth response to IGF-1 by human gastric cancer cells. Gastroenterology 1993; 104:1595-604.
17. Cohen P, Peehl DM, Stamey TA, Wilson KF, Clemmons DR, Rosenfeld RG: Elevated levels of IGF-1 binding protein in the serum of prostate cancer patients. J Clin Endocrinol Metab 1993; 76:1031-1035.
18. Guo Y, Narayan S, Yallampalli, Singh P: Characterization of IGF-1 receptors in human colon cancer. Gastroenterology 1992; 102:1101-1108.
19. Foekens JA, Portengen H, Janssen M, Klijn JGM: Insulin-like growth factor-1 receptors and insulin-like growth factor-1 activity in human primary breast cancer. Cancer 1989; 63:2139-2147.
20. Chung CK, Antoniades HN: Expression of c-sis/platelet derived growth factor B, IGF-1 and TGF-Alfa messenger RNAs and their respective receptor messengers in primary human gastric carcinomas: in vivo studies with in situ hybridization and immunocytochemistry. Cancer Res 1992; 52:3453-3459.
21. Durrant LG, Watson SA, Hall A, Morris DL: Co-stimulation of gastrointestinal tumor cell growth by gastrin, TGF-Alfa and IGF 1. Br J Cancer 1991; 63:67-70.
22. Unterman TG, Vasquez RM, Slas AJ, Martyn PA, Phillips LS: Nutrition and somatomedin. Usefulness of somatomedin-C in nutritional assessment. Am J Med 1985; 78:229-234.
23. Zapf J, Schmid C, Froesch E: Biological and immunological properties of insulin-like growth factor 1 and 2. Clin Endocrinol Metab 1984; 13:3-30.
24. Lee DY, Yang DH, Kang CW, Kim SJ, Joo CU, Cho SC, Kim JS: Serum insulin-like growth factors and IGF binding protein-3 in patients with gastric cancer: IGFBP-3 protease activity induced by surgery. J Korean Med Sci 1997; 12:32-39.
25. Zapf J: Total and free IGF serum levels. Eur J Endocr 1997; 136:146-147.